Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis - ScienceDirect
Relapse rate, overall survival, disease-free survival, and... | Download Scientific Diagram
Overall and relapse-free survival rates in AML cases with and without... | Download Scientific Diagram
Relapses | VUMERITY® (diroximel fumarate)
Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design - Richard Nicholas, Sebastian Straube, Heinz Schmidli, Simon Schneider, Tim Friede, 2011
Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcome - Vannata - 2019 - British Journal of Haematology - Wiley Online Library
Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs – Recovery Research Institute
Cureus | Relapsed Childhood Acute Lymphoblastic Leukemia: A Single-Institution Experience | Article
Cancers | Free Full-Text | Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk | Haematologica
Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program | Annals of General Psychiatry | Full Text
Relapse Prevention Resources and Techniques
Relapse rate following surgery
Modern guidelines improve late relapse rates, outcomes in testicular cancer
Why are Addiction Relapse So High in Early Recovery?
Why Heroin Relapse Rate Is So High
Relapse: The Revolving Door - Infographic - The Ranch PA %
Treatment and Recovery | National Institute on Drug Abuse (NIDA)
COVID-19 Causing Surge in Alcohol Addiction & Relapse Rates
MS Relapse Rates Go Even Lower in Ocrevus Extension Study
Higher Graft T Cell and CD34 Cell Content Is Associated with Earlier Complete Chimerism, Lower Relapse Rates, and Improved Overall Survival (OS) in Recipients Undergoing Matched Related (MR) Myeloablative Hematopoietic Stem Cell
5 Encouraging Ways to Turn an Relapse Into An Opportunity for Growth
